BioNeutra Global Corp Total Assets
BioNeutra Global Corp total assets. Based on the latest financial reports, BioNeutra Global Corp (BGA) holds total assets worth CA$13.57 Million CAD (≈ $9.82 Million USD) as of September 2024. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see market value of BioNeutra Global Corp for the company's overall valuation and market capitalisation.
Total Assets of BioNeutra Global Corp (2013–2023)
Total assets of BioNeutra Global Corp from 2013 to 2023. This chart illustrates how BioNeutra Global Corp's total assets have evolved over time, based on quarterly financial data. See current stock price of BioNeutra Global Corp for real-time trading data and today's change.
BioNeutra Global Corp - Asset Composition Analysis
BioNeutra Global Corp Total Assets Breakdown (December 2023)
BioNeutra Global Corp total assets breakdown as of December 2023. BioNeutra Global Corp's total assets of CA$13.57 Million consist of 44.2% current assets and 55.8% non-current assets.
| Asset Category | Amount (CAD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CA$0.00 | 12.0% |
| Accounts Receivable | CA$1.18 Million | 7.5% |
| Inventory | CA$3.29 Million | 20.9% |
| Property, Plant & Equipment | CA$0.00 | 0.0% |
| Intangible Assets | CA$320.31K | 2.0% |
| Goodwill | CA$0.00 | 0.0% |
Asset Composition Trend (2013–2023)
This chart illustrates how BioNeutra Global Corp's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore BioNeutra Global Corp (BGA) working capital ratio to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: BioNeutra Global Corp's current assets represent 44.2% of total assets in 2023, a decrease from 66.2% in 2013.
- Cash Position: Cash and equivalents constituted 12.0% of total assets in 2023, down from 19.3% in 2013.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 2.0% of total assets, a decrease from 11.0% in 2013.
- Asset Diversification: The largest asset category is inventory at 20.9% of total assets.
BioNeutra Global Corp Competitors by Total Assets
Key competitors of BioNeutra Global Corp based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Nestle S.A.
SW:NESN
|
Switzerland | CHF128.38 Billion |
|
The Magnum Ice Cream Company N.V.
AS:MICC
|
Netherlands | €7.49 Billion |
|
COFCO Tunhe Sugar Co Ltd
SHG:600737
|
China | CN¥22.01 Billion |
|
The a2 Milk Company Ltd
AU:A2M
|
Australia | AU$1.96 Billion |
|
Lotus Health Group Co
SHG:600186
|
China | CN¥3.86 Billion |
|
Grupo Herdez S.A.B. de C.V
MX:HERDEZ
|
Mexico | MX$48.32 Billion |
|
Shandong Oriental Ocean Sci-Tech Co Ltd
SHE:002086
|
China | CN¥1.59 Billion |
|
Namchow Food Group (Shanghai) Co. Ltd.
SHG:605339
|
China | CN¥4.18 Billion |
BioNeutra Global Corp - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.35 | 0.39 | 0.92 |
| Quick Ratio | 0.17 | 0.18 | 0.26 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CA$-9.93 Million | CA$-10.13 Million | CA$-1.89 Million |
BioNeutra Global Corp - Advanced Valuation Insights
This section examines the relationship between BioNeutra Global Corp's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 11.60 |
| Latest Market Cap to Assets Ratio | 0.06 |
| Asset Growth Rate (YoY) | -20.3% |
| Total Assets | CA$15.77 Million |
| Market Capitalization | $1.01 Million USD |
Valuation Analysis
Below Book Valuation: The market values BioNeutra Global Corp's assets below their book value (0.06x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: BioNeutra Global Corp's assets decreased by 20.3% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for BioNeutra Global Corp (2013–2023)
The table below shows the annual total assets of BioNeutra Global Corp from 2013 to 2023.
| Year | Total Assets | Change |
|---|---|---|
| 2023-12-31 | CA$15.77 Million ≈ $11.41 Million |
-20.30% |
| 2022-12-31 | CA$19.78 Million ≈ $14.31 Million |
-6.18% |
| 2021-12-31 | CA$21.08 Million ≈ $15.25 Million |
-10.95% |
| 2020-12-31 | CA$23.68 Million ≈ $17.13 Million |
-30.41% |
| 2019-12-31 | CA$34.02 Million ≈ $24.61 Million |
-14.91% |
| 2018-12-31 | CA$39.99 Million ≈ $28.93 Million |
+29.11% |
| 2017-12-31 | CA$30.97 Million ≈ $22.40 Million |
-15.38% |
| 2016-12-31 | CA$36.60 Million ≈ $26.47 Million |
+36.67% |
| 2015-12-31 | CA$26.78 Million ≈ $19.37 Million |
+93.71% |
| 2014-12-31 | CA$13.82 Million ≈ $10.00 Million |
+123.91% |
| 2013-12-31 | CA$6.17 Million ≈ $4.47 Million |
-- |
About BioNeutra Global Corp
BioNeutra Global Corporation engages in the research and development, production, and commercialization of food for nutraceutical, functional, and mainstream food and beverage products with a focus on oligosaccharides. The company offers isomalt oligosaccharide ingredients under the VitaFiber brand for human digestive health. It operates in Canada, the United States, Australia, New Zealand, Europ… Read more